Neprilysin as a Biomarker: Challenges and Opportunities

Neprilysin as a Biomarker: Challenges and Opportunities

Neprilysin (NEP) inhibition is a successful novel therapeutic approach in heart failure with reduced ejection fraction. Assessing individual NEP status might be important for gathering insights into mechanisms of disease and optimising individualised patient care. NEP is a zinc-dependent multisubstr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Noemi Pavo, Suriya Prausmüller, Philipp E Bartko, Georg Goliasch, Martin Hülsmann
Format:	Article
Language:	English
Published:	Radcliffe Medical Media 2020-08-01
Series:	Cardiac Failure Review
Online Access:	https://www.cfrjournal.com/articles/neprilysin-as-a-biomarker
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Eligibility and GDMT up-titration success in heart failure: A real-world assessment.
by: Annika Weidenhammer, et al.
Published: (2025-01-01)

Use of angiotensin receptor – neprilysin inhibitors in heart failure: a paradigm shift
by: M. O.E. Irhuma, et al.
Published: (2016-11-01)

Neprilysin 2 catalyses the degradation of natriuretic peptides despite sacubitrilat Inhibition
by: Elizaveta M. Selezneva, et al.
Published: (2025-07-01)

Angiotensin Receptor–Neprilysin Inhibitor in Heart Failure Patients With Renal Dysfunction
by: Xiaogang Zhu, et al.
Published: (2024-01-01)

Angiotensin Receptor-Neprilysin Inhibitor for Chronic Kidney Disease: Strategies for Renal Protection
by: Erika Hishida, et al.
Published: (2024-10-01)

Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy
by: Elena Guillén-Gómez, et al.
Published: (2018-01-01)

Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial
by: Rolf Wachter, et al.
Published: (2020-06-01)

Angiotensin receptor‐neprilysin inhibitor adherence and outcomes in heart failure with reduced ejection fraction
by: Dong‐Hyuk Cho, et al.
Published: (2025-02-01)

Angiotensin Receptor‐Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure
by: Andreas A. Boehmer, et al.
Published: (2024-08-01)

Comprehensive review on neprilysin (NEP) inhibitors: design, structure-activity relationships, and clinical applications
by: Xinyue Zhang, et al.
Published: (2024-12-01)

Potential renoprotective effects and possible underlying mechanisms of angiotensin receptor-neprilysin inhibitors in cardiorenal syndrome
by: Md. Moshiur Rahman, et al.
Published: (2025-01-01)

Biomarker repurposing: opportunities and challenges in the evolving field of laboratory medicine
by: Gruson Damien, et al.
Published: (2024-12-01)

Angiotensin Receptor–Neprilysin Inhibition (Sacubitril/Valsartan) Reduces Structural Arterial Stiffness in Middle‐Aged Mice
by: Isabel N. Schellinger, et al.
Published: (2024-02-01)

Effect of Angiotensin Receptor-neprilysin Inhibitor on Acute Kidney Injury in Patients With Acute Decompensated Heart Failure
by: Gonghao Li, et al.
Published: (2024-03-01)

Association of Circulating Neprilysin with BMI, Cardiovascular Health, and Kidney Function in High-Risk Pregnancies: A Pilot Study
by: Kaltrina Kutllovci Hasani, et al.
Published: (2024-12-01)

Revealing Local Structure of Angiotensin Receptor-Neprilysin Inhibitor (S086) Drug Cocrystal by Linear and Nonlinear Infrared Spectroscopies
by: Wenjie Xu, et al.
Published: (2024-12-01)

The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation
by: A. S. Ryazanov, et al.
Published: (2023-01-01)

Emerging role of angiotensin receptor neprilysin inhibitor in right ventricular systolic dysfunction with preserved left ventricular ejection fraction
by: Ertan Yetkin
Published: (2025-05-01)

Barriers in the Nervous System: Challenges and Opportunities for Novel Biomarkers in Amyotrophic Lateral Sclerosis
by: Lorena Pisoni, et al.
Published: (2025-06-01)

Effects of angiotensin receptor–neprilysin inhibition on myocardial energy metabolism and prognosis in patients with acute myocardial infarction complicated by heart failure
by: Caiming Cheng, et al.
Published: (2025-08-01)

Efficacy of angiotensin receptor neprilysin inhibitor for maintenance hemodialysis patients with different types of left ventricular ejection fraction heart failure
by: Jin-cong Li, et al.
Published: (2024-12-01)

Non-Target Screening Approaches in Coffee Research–Opportunities and Challenges
by: Stefan Bieber, et al.
Published: (2024-07-01)

Cardiac function in pregnant women with preeclampsia
by: Gülen Yerlikaya-Schatten, et al.
Published: (2024-12-01)

Studi Docking Molekuler Penghambatan Reseptor Neprilysin Bunga Lawang (Illicium verum) sebagai Anti Hipertensi dan Prediksi Profil Farmakokinetikanya
by: Andri Tilaqza, et al.
Published: (2023-08-01)

LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates epithelial-mesenchymal transition of peritoneal mesothelial cells and M2 macrophage polarization
by: Yan Hu, et al.
Published: (2024-12-01)

The impact of angiotensin-receptor neprilysin inhibitors on cardiovascular events and solute transport function in peritoneal dialysis patients: a multicenter retrospective controlled study
by: Yishu Wang, et al.
Published: (2024-12-01)

Impact of the angiotensin receptor-neprilysin inhibitor on chronic heart failure due to adult congenital heart disease: A systematic review and meta-analysis
by: Bibhuti B. Das, MD, MBA, MHA, et al.
Published: (2025-05-01)

Rhino poaching in Assam: challenges and opportunities
by: Esmond Martin, et al.
Published: (2009-12-01)

The State of Cultural Studies Today – Challenges and Opportunities
by: Hans-Georg Moeller, et al.
Published: (2025-07-01)

CHANGES, OPPORTUNITIES, AND CHALLENGES
by: William M. Healy
Published: (2005-01-01)

Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction
by: Chia-Chen Lee, et al.
Published: (2024-12-01)

AI in the Academe: Opportunities and Challenges for Religious Education
by: Leo-Martin Angelo R. Ocampo, et al.
Published: (2024-06-01)

PROSPECTIVE COMPARISON OF ARNI [ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR] WITH ACEI [ANGIOTENSIN CONVERTING-ENZYME INHIBITOR] TO DETERMINE IMPACT ON GLOBAL MORTALITY AND MORBIDITY IN HEART FAILURE TRIAL
Published: (2016-02-01)

Evaluation of the efficacy of angiotensin receptor–neprilysin inhibitor in patients with aortic stenosis undergoing transcatheter aortic valve implantation: protocol for a randomised, open-label, controlled study
by: Hideki Hanaoka, et al.
Published: (2025-04-01)

Relacje księży Karola Dębińskiego i Feliksa Majewskiego z wizytacji duszpasterskich biskupa lubelskiego Franciszka Jaczewskiego jako źródło do badań architektury sakralnej w diecezji lubelskiej na początku XX wieku
by: Anna Bartko-Malinowska
Published: (2023-06-01)

Distributed teams: challenges and opportunities
by: M. V. Orlova, et al.
Published: (2022-04-01)

Leadership in Healthcare: Challenges and Opportunities
by: Vengamma B
Published: (2025-03-01)

Smart Cities: Challenges and Opportunities
by: Mohammad Ilyas
Published: (2023-08-01)

Challenges and Opportunities in Medical Tourism
by: Nizar Zein
Published: (2025-01-01)

Ethno-federalism: Challenges and opportunities
by: Juhász József
Published: (2005-01-01)